Juan Marco Figueira-Gonçalves

10PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Systems physiologyMajor global burdens of diseaseCell physiologyCross-sectional analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 02, 2026
Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study.

|Jan 19, 2026
Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study.

Juan Marco Figueira-Gonçalves, Bernardino Alcázar-Navarrete, Raquel Casitas-Mateo

|Sep 22, 2025
Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study.

Bernardino Alcázar-Navarrete, Juan Marco Figueira-Gonçalves, Carmen Corregidor-García

|Feb 13, 2025
Resources and Readmission for COPD Exacerbation in Pneumology Units in Spain: The COPD Observatory Project.

Myriam Calle Rubio, Pilar Cebollero Rivas, Cristóbal Esteban

|Apr 10, 2023
Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD.

Ignacio García-Talavera, Juan Marco Figueira-Gonçalves, Rafael Golpe

|Sep 06, 2022
Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk.

Rafael Golpe, Juan Marco Figueira-Gonçalves, Carlos Antonio Amado-Diago

Pageof 2

Frequent Collaborators

6 joint publications

Rafael Golpe

3 joint publications

Eunice Fitas

3 joint publications

Carlos Antonio Amado-Diago

3 joint publications

Carmen Corregidor-García